Survival of MUTYH-associated polyposis patients with colorectal cancer and matched control colorectal cancer patients

Journal of the National Cancer Institute

Volumn 102, Issue 22, 2010, Pages 1724-1730

  Nielsen, Maartje ^a   Van Steenbergen, Liza N ^b   Jones, Natalie ^c   Vogt, Stefanie ^d   Vasen, Hans F A ^b   Morreau, Hans ^a   Aretz, Stefan ^d   Sampson, Julian R ^c   Dekkers, Olaf M ^a   Janssen Heijnen, Maryska L G ^b,e   Hes, Frederik J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Research Eindhoven Cancer Registry ^*  (Germany)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF BONN   (Germany)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; COLORECTAL CANCER; FEMALE; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; MUTYH GENE; PHENOTYPE; POLYPOSIS; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; BIAS (EPIDEMIOLOGY); CASE-CONTROL STUDIES; COLONIC POLYPS; COLORECTAL NEOPLASMS; DNA GLYCOSYLASES; EUROPE; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SELECTION BIAS;

EID: 78649337092     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djq370     Document Type: Article

References (37)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(3):74-108.
2. Sankila R, Aaltonen LA, Jarvinen HJ, et al. Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology. 1996;110(3):682-687.
3. Watson P, Lin KM, Rodriguez-Bigas MA, et al. Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer. 1998;83(2):259-266. (Pubitemid 28317805)
4. Lynch HT, Bardawil WA, Harris RE, et al. Multiple primary cancers and prolonged survival: familial colonic and endometrial cancers. Dis Colon Rectum. 1978;21(3):165-168.
5. Stigliano V, Assisi D, Cosimelli M, et al. Survival of hereditary non-polyposis colorectal cancer patients compared with sporadic colorectal cancer patients. J Exp Clin Cancer Res. 2008;27:39.
6. Gryfe R, Kim H, Hsieh ET, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med. 2000;342(2):69-77.
7. Myrhoj T, Bisgaard ML, Bernstein I, et al. Hereditary non-polyposis co-lorectal cancer: clinical features and survival. Results from the Danish HNPCC register. Scand J Gastroenterol. 1997;32(6):572-576.
8. Tomoda H, Baba H, Akazawa K. Prolonged survival in hereditary nonpol-yposis colorectal cancer. Oncol Rep. 1999;6(2):321-324.
9. Barnetson RA, Tenesa A, Farrington SM, et al. Identifcation and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med. 2006;354(26):2751-2763.
10. Feeley KM, Fullard JF, Heneghan MA, et al. Microsatellite instability in sporadic colorectal carcinoma is not an indicator of prognosis. J Pathol. 1999;188(1):14-17.
11. Percesepe A, Benatti P, Roncucci L, et al. Survival analysis in families affected by hereditary non-polyposis colorectal cancer. Int J Cancer. 1997; 71(3):373-376. (Pubitemid 27224300)
12. Salahshor S, Kressner U, Fischer H, et al. Microsatellite instability in sporadic colorectal cancer is not an independent prognostic factor. Br J Cancer. 1999;81(2):190-193.
13. Al Tassan N, Eisen T, Maynard J, et al. Inherited variants in MYH are unlikely to contribute to the risk of lung carcinoma. Hum Genet. 2004;114(2):207-210.
14. Lubbe SJ, Di Bernardo MC, Chandler IP, et al. Clinical implications of the colorectal cancer risk associated with MUTYH mutation. J Clin Oncol. 2009;27(24):3975-3980.
15. Croitoru ME, Cleary SP, Di Nicola N, et al. Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. J Natl Cancer Inst. 2004;96(21):1631-1634.
16. Farrington SM, Tenesa A, Barnetson R, et al. Germline susceptibility to colorectal cancer due to base-excision repair gene defects. Am J Hum Genet. 2005;77(1):112-119.
17. Nielsen M, Franken PF, Reinards TH, et al. Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP). J Med Genet. 2005;42(9):e54.
18. Aretz S, Uhlhaas S, Goergens H, et al. MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype. Int J Cancer. 2006;119(4):807-814.
19. Sampson JR, Dolwani S, Jones S, et al. Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet. 2003; 362(9377):39-41.
20. Out AA, Tops CM, Nielsen M, et al. Leiden open variation database of the MUTYH gene Hum Mutat. 2010 [Epub ahead of print].
21. Fritz A, Percy C, Jack A, et al. International Classifcation of Diseases for Oncology. Geneva, Switzerland: World Health Organisation; 2000.
22. UICC. TNM Classifcation of Malignant Tumours. New York, NY: Wiley-Liss, 2002.
23. Brenner H, Stegmaier C, Ziegler H. Estimating completeness of cancer registration in Saarland/Germany with capture-recapture methods. Eur J Cancer. 1994;30A:1659-1663.
24. Janssen-Heijnen MLG, Louwman WJ, van de Poll-Franse LV, et al. Results of 50 Years Cancer Registry in the South of the Netherlands: 1955-2004 (in Dutch). Eindhoven, the Netherlands: Eindhoven Cancer Registry; 2005.
25. Clark AJ, Barnetson R, Farrington SM, et al. Prognosis in DNA mismatch repair defcient colorectal cancer: are all MSI tumours equivalent? Fam Cancer. 2004;3(2):85-91.
26. Hampel H, Stephens JA, Pukkala E, et al. Cancer risk in hereditary non-polyposis colorectal cancer syndrome: later age of onset. Gastroenterology. 2005;129(2):415-421.
27. Van Puijenbroek M, Nielsen M, Tops CM, et al. Identifcation of patients with (atypical) MUTYH-associated polyposis by KRAS2 c.34G > T prescreening followed by MUTYH hotspot analysis in formalin-fxed paraffn-embedded tissue. Clin Cancer Res. 2008;14(1):139-142.
28. Cleary SP, Cotterchio M, Jenkins MA, et al. Germline MutY human ho-mologue mutations and colorectal cancer: a multisite case-control study. Gastroenterology. 2009;136(4):1251-1260.
29. Galon J, Costes A, Sanchez-Cabo F, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006;313(5795):1960-1964.
30. Naito Y, Saito K, Shiiba K, et al. CD8+ T cells infltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res. 1998;58(16):3491-3494.
31. Ropponen KM, Eskelinen MJ, Lipponen PK, et al. Prognostic value of tumour-infltrating lymphocytes (TILs) in colorectal cancer. J Pathol. 1997;182(3):318-324.
32. Guidoboni M, Gafa R, Viel A, et al. Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. Am J Pathol. 2001;159(1):297-304.
33. Smyrk TC, Watson P, Kaul K, et al. Tumor-infltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma. Cancer. 2001;91(12):2417-2422.
34. Nielsen M, de Miranda NF, van PM, et al. Colorectal carcinomas in MUTYH-associated polyposis display histopathological similarities to microsatellite unstable carcinomas. BMC Cancer. 2009;9:184.
35. Kloor M, Becker C, Benner A, et al. Immunoselective pressure and human leukocyte antigen class I antigen machinery defects in microsatellite unstable colorectal cancers. Cancer Res. 2005;65(14):6418-6424.
36. Dierssen JW, de Miranda NF, Ferrone S, et al. HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression. BMC Cancer. 2007;7:33.
37. De Miranda NF, Nielsen M, Pereira D, et al. MUTYH-associated polypo-sis carcinomas frequently lose HLA class I expression-a common event amongst DNA-repair-deficient colorectal cancers. J Pathol. 2009;219(1):69-76.